CUSIP: 576314108
Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,925,369
-
Share change
-
+405,728
-
Total reported value
-
$2,520,000
-
Put/Call ratio
-
0.91%
-
Price per share
-
$0.11
-
Number of holders
-
20
-
Value change
-
-$3,003,218
-
Number of buys
-
11
-
Number of sells
-
15
Quarterly Holders Quick Answers
What is CUSIP 576314108?
CUSIP 576314108 identifies MSTX - MAST THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2016
-
Previous quarter:
Q2 2016
Recent filing periods for CUSIP 576314108:
Institutional Holders of MAST THERAPEUTICS INC - COM (MSTX) as of Q3 2016
As of 30 Sep 2016,
MAST THERAPEUTICS INC - COM (MSTX) was held by
20 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,925,369 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock Institutional Trust Company, N.A., RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, PERKINS CAPITAL MANAGEMENT INC, CREDIT SUISSE AG/, Creative Planning, HighTower Advisors, LLC, and NORTHERN TRUST CORP.
This page lists
20
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.